Image: Getty Images/ For illustrative purposes
M42, a global health leader powered by artificial intelligence (AI), technology and genomics, on Monday announced the incorporation of M42 Saudi Arabia, marking a new phase in its partnership with the kingdom and reinforcing its support for Saudi Arabia’s Vision 2030 healthcare transformation.
The announcement was made during the Global Health Exhibition (GHE) in Riyadh, highlighting the company’s commitment to advancing precision, preventive and predictive healthcare across the kingdom.
Building on over 12 years of collaboration with the Saudi Ministry of Health (MoH) through the operation of more than 40 Diaverum clinics across 33 cities, including Riyadh, Jeddah, Makkah and Madinah, M42 said the new entity represents the next stage in a “trusted partnership grounded in performance, impact and shared purpose.”
M42 Saudi Arabia to support advanced patient care
Under M42 Saudi Arabia, the company will continue providing renal care through its Diaverum network while expanding into areas such as multi-omics, population health programmes, metabolic and lifestyle disease management, and digital integration.
The launch aligns with M42’s goal to partner with Saudi Arabia in realising its Vision 2030 ambition for a future-ready and sustainable health system, focusing on advanced patient care and the kingdom’s growing life sciences sector, including clinical trials and R&D.
“The incorporation of M42 Saudi Arabia is a natural step for us in building a globally scaled health intelligence ecosystem that works in partnership with local institutions to shift from reactive care to precision, prevention and prediction,” said Dimitris Moulavasilis, group CEO at M42.
Ziyad Kabli, COO for the Middle East and Asia at M42, added: “For more than a decade, our work in Saudi Arabia has centred on providing high-quality renal care through Diaverum. The launch of M42 Saudi Arabia marks our expansion from specialty services to system-wide collaboration in precision, preventive and predictive health.”
The company said the incorporation will enable Saudi-led pilot programmes, collaborative research, and partnerships with government and private healthcare institutions, reinforcing the kingdom’s leadership in innovation-driven health delivery.
The expansion follows M42’s broader regional growth, including the launch of Jordan’s first virtual hospital, the Digital Health Centre, in collaboration with the Jordanian Ministry of Health and Ministry of Digital Economy and Entrepreneurship.
In Bahrain, M42 is partnering with Mumtalakat through Amana Healthcare – Bahrain to provide long-term care and post-acute rehabilitation services in Al Jasra.
